Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)

P Wolf; W Weger; L Richter; A Mlynek; P Sator; W Saxinger; G Ratzinger; C Kolli; C Painsi; C Bangert; R Tatarski; M Schutz-Bergmayr; P Ponholzer; F Trautinger; R Strohal; R Mullegger; M Inzinger; R Lichem; W Salmhofer; F Quehenberger

Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)

P Wolf, W Weger, L Richter, A Mlynek, P Sator, W Saxinger, G Ratzinger, C Kolli, C Painsi, C Bangert, R Tatarski, M Schutz-Bergmayr, P Ponholzer, F Trautinger, R Strohal, R Mullegger, M Inzinger, R Lichem, W Salmhofer, F Quehenberger

Department of Dermatology and Allergology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	E250-E250
Journal	BRITISH JOURNAL OF DERMATOLOGY
Volume	177
Issue number	5
Publication status	Published - 2017
Event	8th International Congress on Psoriasis Gene to Clinic - London, ENGLAND Duration: 30 Nov 2017 → 2 Dec 2017

Cite this

Wolf, P., Weger, W., Richter, L., Mlynek, A., Sator, P., Saxinger, W., Ratzinger, G., Kolli, C., Painsi, C., Bangert, C., Tatarski, R., Schutz-Bergmayr, M., Ponholzer, P., Trautinger, F., Strohal, R., Mullegger, R., Inzinger, M., Lichem, R., Salmhofer, W., & Quehenberger, F. (2017). Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA). BRITISH JOURNAL OF DERMATOLOGY, 177(5), E250-E250.

@article{b01fd42cf2d04237b801d0bd34dd287d,

title = "Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)",

author = "P Wolf and W Weger and L Richter and A Mlynek and P Sator and W Saxinger and G Ratzinger and C Kolli and C Painsi and C Bangert and R Tatarski and M Schutz-Bergmayr and P Ponholzer and F Trautinger and R Strohal and R Mullegger and M Inzinger and R Lichem and W Salmhofer and F Quehenberger",

year = "2017",

language = "English",

volume = "177",

pages = "E250--E250",

journal = "BRITISH JOURNAL OF DERMATOLOGY",

issn = "0007-0963",

publisher = "Blackwell Verlag",

number = "5",

note = "8th International Congress on Psoriasis Gene to Clinic ; Conference date: 30-11-2017 Through 02-12-2017",

}

Wolf, P, Weger, W, Richter, L, Mlynek, A, Sator, P, Saxinger, W, Ratzinger, G, Kolli, C, Painsi, C, Bangert, C, Tatarski, R, Schutz-Bergmayr, M, Ponholzer, P, Trautinger, F, Strohal, R, Mullegger, R, Inzinger, M, Lichem, R, Salmhofer, W & Quehenberger, F 2017, 'Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)', BRITISH JOURNAL OF DERMATOLOGY, vol. 177, no. 5, pp. E250-E250.

TY - JOUR

T1 - Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)

AU - Wolf, P

AU - Weger, W

AU - Richter, L

AU - Mlynek, A

AU - Sator, P

AU - Saxinger, W

AU - Ratzinger, G

AU - Kolli, C

AU - Painsi, C

AU - Bangert, C

AU - Tatarski, R

AU - Schutz-Bergmayr, M

AU - Ponholzer, P

AU - Trautinger, F

AU - Strohal, R

AU - Mullegger, R

AU - Inzinger, M

AU - Lichem, R

AU - Salmhofer, W

AU - Quehenberger, F

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 0007-0963

VL - 177

SP - E250-E250

JO - BRITISH JOURNAL OF DERMATOLOGY

JF - BRITISH JOURNAL OF DERMATOLOGY

IS - 5

T2 - 8th International Congress on Psoriasis Gene to Clinic

Y2 - 30 November 2017 through 2 December 2017

ER -